AQR Capital Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.64M Buy
930,196
+309,601
+50% +$2.54M 0.01% 1081
2025
Q1
$4.44M Buy
620,595
+594,161
+2,248% +$4.25M ﹤0.01% 1181
2024
Q4
$204K Sell
26,434
-9,823
-27% -$75.9K ﹤0.01% 2664
2024
Q3
$380K Buy
36,257
+15,878
+78% +$167K ﹤0.01% 2286
2024
Q2
$238K Buy
+20,379
New +$238K ﹤0.01% 2356
2024
Q1
Sell
-22,052
Closed -$396K 2489
2023
Q4
$396K Sell
22,052
-27
-0.1% -$485 ﹤0.01% 1972
2023
Q3
$363K Sell
22,079
-2,477
-10% -$40.8K ﹤0.01% 1958
2023
Q2
$491K Sell
24,556
-58,746
-71% -$1.17M ﹤0.01% 1792
2023
Q1
$1.58M Sell
83,302
-155,613
-65% -$2.94M ﹤0.01% 1351
2022
Q4
$5.42M Buy
238,915
+45,411
+23% +$1.03M 0.01% 854
2022
Q3
$5.11M Buy
193,504
+50,439
+35% +$1.33M 0.01% 830
2022
Q2
$3.53M Buy
143,065
+102,574
+253% +$2.53M 0.01% 894
2022
Q1
$1.34M Buy
+40,491
New +$1.34M ﹤0.01% 1394
2021
Q2
Sell
-8,786
Closed -$300K 2286
2021
Q1
$300K Buy
8,786
+3,278
+60% +$112K ﹤0.01% 2007
2020
Q4
$250K Sell
5,508
-9,286
-63% -$421K ﹤0.01% 2023
2020
Q3
$407K Buy
14,794
+5,313
+56% +$146K ﹤0.01% 1808
2020
Q2
$349K Buy
9,481
+559
+6% +$20.6K ﹤0.01% 1848
2020
Q1
$289K Sell
8,922
-8,147
-48% -$264K ﹤0.01% 1767
2019
Q4
$699K Sell
17,069
-22,885
-57% -$937K ﹤0.01% 1640
2019
Q3
$1.42M Sell
39,954
-100,771
-72% -$3.59M ﹤0.01% 1403
2019
Q2
$7.23M Sell
140,725
-100,992
-42% -$5.19M 0.01% 851
2019
Q1
$13.9M Sell
241,717
-48,933
-17% -$2.8M 0.01% 685
2018
Q4
$12.2M Buy
290,650
+78,820
+37% +$3.31M 0.01% 671
2018
Q3
$16M Buy
211,830
+35,915
+20% +$2.71M 0.02% 639
2018
Q2
$12.6M Buy
175,915
+115,912
+193% +$8.32M 0.01% 716
2018
Q1
$1.79M Buy
60,003
+26,973
+82% +$805K ﹤0.01% 1405
2017
Q4
$1.1M Sell
33,030
-4,853
-13% -$161K ﹤0.01% 1644
2017
Q3
$1.25M Sell
37,883
-14,375
-28% -$474K ﹤0.01% 1589
2017
Q2
$1.03M Buy
+52,258
New +$1.03M ﹤0.01% 1661